CBU
EVH icon

CIBC Bancorp USA’s Evolent Health EVH Stock Holding History

CIBC Bancorp USA’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$106K Buy
+12,511
New +$121K ﹤0.01% 1351

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIBC Bancorp USA's EVH Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Evolent Health (EVH) in Q3 2025: 12,511 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #1351 among its holdings.

240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • CIBC Bancorp USA held 12,511 shares of Evolent Health worth $106K as of Q3 2025.
  • Evolent Health was a new CIBC Bancorp USA position in Q3 2025.
  • Evolent Health made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1351 holding.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.